![]() |
|
![]() |
#1 | ||||||
Professor
Join Date: Nov 2008
Location: the edge of the abyss
Posts: 1,947
|
Quote:
Quote:
Quote:
Quote:
Quote:
Quote:
|
||||||
![]() |
![]() |
![]() |
#2 | ||
barely disguised asshole, keeper of all that is holy.
Join Date: Nov 2007
Posts: 23,401
|
Quote:
Barney Frank is the Chairman of the Financial Services Committee. Committee Members The #1 guy responsible for oversight. And paid rather handsomely for it as well. Do you think he owes us a refund too? Here is just a tidbit from the site: Quote:
__________________
"like strapping a pillow on a bull in a china shop" Bullitt Last edited by classicman; 03-05-2009 at 07:14 PM. |
||
![]() |
![]() |
![]() |
#3 |
Horrible Bastard
Join Date: Feb 2009
Location: High Desert, Arizona
Posts: 1,103
|
Why? It's the only one that works.
__________________
What can we do to help you stop screaming? |
![]() |
![]() |
![]() |
#4 | |
Professor
Join Date: Nov 2008
Location: the edge of the abyss
Posts: 1,947
|
Quote:
http://www.nybooks.com/articles/17244 "...Third, the industry is hardly a model of American free enterprise. To be sure, it is free to decide which drugs to develop (me-too drugs instead of innovative ones, for instance), and it is free to price them as high as the traffic will bear, but it is utterly dependent on government-granted monopolies—in the form of patents and Food and Drug Administration (FDA)–approved exclusive marketing rights. If it is not particularly innovative in discovering new drugs, it is highly innovative—and aggressive—in dreaming up ways to extend its monopoly rights..." "...Drug industry expenditures for research and development, while large, were consistently far less than profits. For the top ten companies, they amounted to only 11 percent of sales in 1990, rising slightly to 14 percent in 2000. The biggest single item in the budget is neither R&D nor even profits but something usually called "marketing and administration"—a name that varies slightly from company to company. In 1990, a staggering 36 percent of sales revenues went into this category, and that proportion remained about the same for over a decade.[13] Note that this is two and a half times the expenditures for R&D. These figures are drawn from the industry's own annual reports to the Securities and Exchange Commission (SEC) and to stockholders, but what actually goes into these categories is not at all clear, because drug companies hold that information very close to their chests. It is likely, for instance, that R&D includes many activities most people would consider marketing, but no one can know for sure. For its part, "marketing and administration" is a gigantic black box that probably includes what the industry calls "education," as well as advertising and promotion, legal costs, and executive salaries—which are whopping. According to a report by the non-profit group Families USA, the for-mer chairman and CEO of Bristol-Myers Squibb, Charles A. Heimbold Jr., made $74,890,918 in 2001, not counting his $76,095,611 worth of unexercised stock options. The chairman of Wyeth made $40,521,011, exclusive of his $40,629,459 in stock options. And so on..." "...This is an industry that in some ways is like the Wizard of Oz—still full of bluster but now being exposed as something far different from its image. Instead of being an engine of innovation, it is a vast marketing machine. Instead of being a free market success story, it lives off government-funded research and monopoly rights. Yet this industry occupies an essential role in the American health care system, and it performs a valuable function, if not in discovering important new drugs at least in developing them and bringing them to market. But big pharma is extravagantly rewarded for its relatively modest functions. We get nowhere near our money's worth. The United States can no longer afford it in its present form..." http://www.pnhp.org/news/2001/july/n..._debunks_d.php "...¤ The actual after-tax cash outlay - or what drug companies really spend on R&D - for each new drug (including failures) according to the DiMasi study is approximately $108 million. (That's in year 2000 dollars, based on data provided by drug companies.) [See Section I] ¤ A simpler measure - also derived from data provided by the industry - suggests that after-tax R&D costs ranged from $69 million to $87 million for each new drug created in the 1990s, including failures. [See Section II] ¤ Industry R&D costs are reduced by taxpayer-funded research, which has helped launch the most medically important drugs in recent years and many of the best-selling drugs, including all of the top five sellers in one recent year. ¤ An internal National Institutes of Health (NIH) document, obtained by Public Citizen through the Freedom of Information Act, shows how crucial taxpayer-funded research is to top-selling drugs. According to the NIH, taxpayer-funded scientists or foreign universities conducted 85 percent of the research projects that led to the discovery and development of the top five selling drugs in 1995. [See Section III]..." http://survivreausida.net/a4915-rx-r...drug-indu.html "...Public Citizen based the study on an extensive review of government and industry data and a report obtained through the Freedom of Information Act from the National Institutes of Health (NIH). Among the report’s key findings : * The actual after-tax cash outlay - what drug companies really spend on R&D for each new drug (including failures) - is approximately $110 million (in year 2000 dollars.) This is in marked contrast with the $500 million figure PhRMA frequently touts. * The NIH document shows how crucial taxpayer-funded research is to the development of top-selling drugs. According to the NIH, U.S. taxpayer-funded scientists conducted at least 55 percent of the research projects that led to the discovery and development of the five top-selling drugs in 1995. * Public Citizen found that, at most, about 22 percent of the new drugs brought to market in the past two decades were innovative drugs that represented important therapeutic advances. Most new drugs were "me-too" or copycat drugs that have little or no therapeutic gain over existing drugs, undercutting the industry’s claim that R&D expenses are used to discover new treatments for serious and life-threatening illnesses. A second report issued today by Public Citizen, The Other Drug War : Big Pharma’s 625 Washington Lobbyists, examines how the U.S. drug industry spent an unprecedented $262 million on political influence in the 1999-2000 election cycle. That includes $177 million on lobbying, $65 million on issue ads and $20 million on campaign contributions. The report shows that : * The drug industry hired 625 different lobbyists last year — or more than one lobbyist for every member of Congress — to coax, cajole and coerce lawmakers. The one-year bill for this team of lobbyists was $92.3 million, a $7.2 million increase over what the industry spent for lobbyists in 1999..." "...The drug industry is stealing from us twice," Clemente said. "First it claims that it needs huge profits to develop new drugs, even while drug companies get hefty taxpayer subsidies. Second, the companies gouge taxpayers while spending millions from their profits to buy access to lawmakers and defeat pro-consumer prescription drug legislation..." |
|
![]() |
![]() |
![]() |
#5 |
barely disguised asshole, keeper of all that is holy.
Join Date: Nov 2007
Posts: 23,401
|
What drives innovation? What gives people the desire to achieve, to overcome to bust their asses for 80- 100 hours a week and take all the risks needed to be successful?
Greed seems like the simplest answer to me. Can we somehow control that while not stifling it? THAT, I believe, is the challenge faced. Especially with so much global competition.
__________________
"like strapping a pillow on a bull in a china shop" Bullitt |
![]() |
![]() |
![]() |
#6 | |
Slattern of the Swail
Join Date: Jul 2004
Posts: 15,654
|
Quote:
If by "successful" you mean having lots of stuff, then it's advertising. Oh, and a small-ish penis.
__________________
In Barrie's play and novel, the roles of fairies are brief: they are allies to the Lost Boys, the source of fairy dust and ...They are portrayed as dangerous, whimsical and extremely clever but quite hedonistic. "Shall I give you a kiss?" Peter asked and, jerking an acorn button off his coat, solemnly presented it to her. —James Barrie Wimminfolk they be tricksy. - ZenGum |
|
![]() |
![]() |
![]() |
#7 |
Professor
Join Date: Nov 2008
Location: the edge of the abyss
Posts: 1,947
|
|
![]() |
![]() |
![]() |
#9 | |
Professor
Join Date: Nov 2008
Location: the edge of the abyss
Posts: 1,947
|
Quote:
|
|
![]() |
![]() |
![]() |
#10 | |
Horrible Bastard
Join Date: Feb 2009
Location: High Desert, Arizona
Posts: 1,103
|
Quote:
The corporation I work for won't hire an MBA. Everyone in management is some form of chemical engineer. But it's not an American company, and is thus not quite as stupid.
__________________
What can we do to help you stop screaming? |
|
![]() |
![]() |
![]() |
#11 |
Horrible Bastard
Join Date: Feb 2009
Location: High Desert, Arizona
Posts: 1,103
|
Yes, it's called regulation. And it worked just fine from the 30s until Carter and all the dumbfucks after him.
__________________
What can we do to help you stop screaming? |
![]() |
![]() |
![]() |
#12 | |
Read? I only know how to write.
Join Date: Jan 2001
Posts: 11,933
|
Quote:
Use Einstein as an example. Or Bill Gates. Or Bill and Dave (Hewlett and Packard). In every case, challenge and accomplishment was the overriding objective. In studies, what was the number one reason for working? Satisfaction. Income was number three. World's greatest innovators are driven first and foremost by the challenge and resulting accomplishment. Why are the most successful major companies lead by some of the lower paid executives? How to find a company most likely to be in trouble? Its executives are the highest paid. They are greedy rather than accomplished. Therefore they neither do nor promote innovation. Those most driven by greed tend to be the greatest enemies of innovation. |
|
![]() |
![]() |
![]() |
#15 |
Professor
Join Date: Nov 2008
Location: the edge of the abyss
Posts: 1,947
|
|
![]() |
![]() |
![]() |
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
|
|